IBDEI1FI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,438,0)
 ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^40
 ;;^UTILITY(U,$J,358.4,439,0)
 ;;=DEST MAL LESION-FACE,MUCOUS^3^40
 ;;^UTILITY(U,$J,358.4,440,0)
 ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^8^40
 ;;^UTILITY(U,$J,358.4,441,0)
 ;;=EXC-BEN LESION-FACE,MUCOUS^7^40
 ;;^UTILITY(U,$J,358.4,442,0)
 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^11^40
 ;;^UTILITY(U,$J,358.4,443,0)
 ;;=EXC-MAL LESION-FACE,MUCOUS^10^40
 ;;^UTILITY(U,$J,358.4,444,0)
 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^31^40
 ;;^UTILITY(U,$J,358.4,445,0)
 ;;=SHAVING-EPIDERM-FACE,MUCOUS^30^40
 ;;^UTILITY(U,$J,358.4,446,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^28^40
 ;;^UTILITY(U,$J,358.4,447,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^26^40
 ;;^UTILITY(U,$J,358.4,448,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^25^40
 ;;^UTILITY(U,$J,358.4,449,0)
 ;;=WOUND HEALING^38^40
 ;;^UTILITY(U,$J,358.4,450,0)
 ;;=SKIN TEST^33^40
 ;;^UTILITY(U,$J,358.4,451,0)
 ;;=MICROBIOLOGY^15^40
 ;;^UTILITY(U,$J,358.4,452,0)
 ;;=MOHS CHEMOSURGERY^17^40
 ;;^UTILITY(U,$J,358.4,453,0)
 ;;=INJECTIONS^14^40
 ;;^UTILITY(U,$J,358.4,454,0)
 ;;=PEEL^19^40
 ;;^UTILITY(U,$J,358.4,455,0)
 ;;=PHOTOTHERAPY^20^40
 ;;^UTILITY(U,$J,358.4,456,0)
 ;;=REPAIR-COMPLEX-FACE^21^40
 ;;^UTILITY(U,$J,358.4,457,0)
 ;;=REPAIR-COMPLEX-NK/HAND/FT^22^40
 ;;^UTILITY(U,$J,358.4,458,0)
 ;;=REPAIR-COMPLEX-TRUNK^24^40
 ;;^UTILITY(U,$J,358.4,459,0)
 ;;=TISSUE REARRANGEMENT-FACE/NECK/HAND/FOOT^35^40
 ;;^UTILITY(U,$J,358.4,460,0)
 ;;=TISSUE REARRANGEMENT-SCALP/ARMS/LEGS^36^40
 ;;^UTILITY(U,$J,358.4,461,0)
 ;;=TISSUE REARRANGEMENT-TRUNK^37^40
 ;;^UTILITY(U,$J,358.4,462,0)
 ;;=REPAIR-COMPLEX-SCALP^23^40
 ;;^UTILITY(U,$J,358.4,463,0)
 ;;=TISSUE REARRANGEMENT-EYELID/NOSE/EAR/LIP^34^40
 ;;^UTILITY(U,$J,358.4,464,0)
 ;;=BIOPSY^1^40
 ;;^UTILITY(U,$J,358.4,465,0)
 ;;=NEW PATIENT^3^41
 ;;^UTILITY(U,$J,358.4,466,0)
 ;;=ESTABLISHED PATIENT^1^41
 ;;^UTILITY(U,$J,358.4,467,0)
 ;;=CONSULTATIONS^2^41
 ;;^UTILITY(U,$J,358.4,468,0)
 ;;=RISK FACTOR REDUCTION-INDIV^7^42
 ;;^UTILITY(U,$J,358.4,469,0)
 ;;=OTHER^3^42
 ;;^UTILITY(U,$J,358.4,470,0)
 ;;=EDUCATION/TRAINING^1^42
 ;;^UTILITY(U,$J,358.4,471,0)
 ;;=MEDICAL NUTRITION THERAPY^2^42
 ;;^UTILITY(U,$J,358.4,472,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^5^42
 ;;^UTILITY(U,$J,358.4,473,0)
 ;;=PREVENTIVE MEDICINE-EST PT^4^42
 ;;^UTILITY(U,$J,358.4,474,0)
 ;;=RISK FACTOR REDUCTION-GRP^6^42
 ;;^UTILITY(U,$J,358.4,475,0)
 ;;=DIABETES W/O COMPLICATION^1^43
 ;;^UTILITY(U,$J,358.4,476,0)
 ;;=DIABETES W/KETOACIDOSIS^3^43
 ;;^UTILITY(U,$J,358.4,477,0)
 ;;=DIABETES W/HYPEROSMOLARITY^2^43
 ;;^UTILITY(U,$J,358.4,478,0)
 ;;=DIABETES W/OTHER COMA^6^43
 ;;^UTILITY(U,$J,358.4,479,0)
 ;;=DIABETES W/RENAL MANIFESTATIONS^9^43
 ;;^UTILITY(U,$J,358.4,480,0)
 ;;=DIABETES W/NEUR MANIFESTATIONS  ^4^43
 ;;^UTILITY(U,$J,358.4,481,0)
 ;;=DIABETES W/PERIPH. CIRC D/O'S    ^8^43
 ;;^UTILITY(U,$J,358.4,482,0)
 ;;=DIABETES W/OTHER SPECIFIED MANIFEST^7^43
 ;;^UTILITY(U,$J,358.4,483,0)
 ;;=DIABETES W/UNSPEC. COMPLICATION^10^43
 ;;^UTILITY(U,$J,358.4,484,0)
 ;;=ADDITIONAL RENAL MANIFESTATIONS^12^43
 ;;^UTILITY(U,$J,358.4,485,0)
 ;;=NERVE ROOT AND PLEXUS DISORDERS^15^43
 ;;^UTILITY(U,$J,358.4,486,0)
 ;;=ADDITIONAL PERIPHERAL CIRC. MANIFEST.^11^43
 ;;^UTILITY(U,$J,358.4,487,0)
 ;;=ADDITIONAL SPECIFIED MANIFESTIONS^13^43
 ;;^UTILITY(U,$J,358.4,488,0)
 ;;=MISCELLANEOUS^14^43
 ;;^UTILITY(U,$J,358.4,489,0)
 ;;=SECONDARY DIABETES^16^43
 ;;^UTILITY(U,$J,358.4,490,0)
 ;;=DIABETES W/OPHTH MANIFESTATIONS^5^43
 ;;^UTILITY(U,$J,358.4,491,0)
 ;;=ASSOCIATED D/O,SIGNS AND SYMPTOMS^17^43
 ;;^UTILITY(U,$J,358.4,492,0)
 ;;=ESTABLISHED PATIENT^2^44
